Literature DB >> 19561871

H.p. Acthar gel and cosyntropin review: clinical and financial implications.

Jacob Gettig1, Joseph P Cummings, Karl Matuszewski.   

Abstract

Year:  2009        PMID： 19561871      PMCID： PMC2697107     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  19 in total

1.  The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.

Authors:  Andrew L Lux; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

2.  Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.

Authors:  F Vigevano; M R Cilio
Journal:  Epilepsia       Date:  1997-12       Impact factor: 5.864

Review 3.  Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.

Authors:  D E Goodkin
Journal:  West J Med       Date:  1994-09

4.  Double-blind study of ACTH vs prednisone therapy in infantile spasms.

Authors:  R A Hrachovy; J D Frost; P Kellaway; T E Zion
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

5.  Infantile spasms. Comparative trial of nitrazepam and corticotropin.

Authors:  F Dreifuss; J Farwell; G Holmes; C Joseph; L Lockman; J A Madsen; C J Minarcik; A D Rothner; D A Shewmon
Journal:  Arch Neurol       Date:  1986-11

Review 6.  Treatment of infantile spasms: an evidence-based approach.

Authors:  Mark Mackay; Shelly Weiss; O Carter Snead
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 7.  Treatment of infantile spasms.

Authors:  E Hancock; J P Osborne; P Milner
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 8.  Diagnosis of adrenal insufficiency.

Authors:  Richard I Dorin; Clifford R Qualls; Lawrence M Crapo
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

Review 9.  Treatment of infantile spasms.

Authors:  S T Haines; D T Casto
Journal:  Ann Pharmacother       Date:  1994-06       Impact factor: 3.154

Review 10.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910
View more
  12 in total

1.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

Review 2.  Recent advances in the pharmacotherapy of infantile spasms.

Authors:  Raili Riikonen
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

Review 3.  Leveraging melanocortin pathways to treat glomerular diseases.

Authors:  Rujun Gong
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

4.  Acquired Resistance to Corticotropin Therapy in Nephrotic Syndrome: Role of De Novo Neutralizing Antibody.

Authors:  Pei Wang; Yan Zhang; Yu Wang; Andrew S Brem; Zhangsuo Liu; Rujun Gong
Journal:  Pediatrics       Date:  2017-07       Impact factor: 7.124

5.  Trends and Costs Associated With the Diagnosis and Treatment of Infantile Spasms: A 10-Year Multicenter Retrospective Review.

Authors:  Mindl M Weingarten; Jon A Cokley; Brady Moffett; Shannon DiCarlo; Sunita N Misra
Journal:  J Pediatr Pharmacol Ther       Date:  2021-12-22

Review 6.  Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms.

Authors:  D A Iacobas; S Iacobas; T Chachua; C Goletiani; G Sidyelyeva; J Velíšková; L Velíšek
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

7.  Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies.

Authors:  Snehal Shrivastava; Bohan Chen; Lance D Dworkin; Deepak K Malhotra; Rujun Gong
Journal:  Am J Nephrol       Date:  2020-03-18       Impact factor: 3.754

Review 8.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

9.  ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation.

Authors:  Hasan Arrat; Thomas J Lukas; Teepu Siddique
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

Review 10.  Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.

Authors:  Michael Philbin; John Niewoehner; George J Wan
Journal:  Adv Ther       Date:  2017-06-28       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.